nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Can we unlock the potential of IGF-1R inhibition in cancer therapy?
|
King, Helen |
|
2014 |
40 |
9 |
p. 1096-1105 10 p. |
artikel |
2 |
Durable benefit and the potential for long-term survival with immunotherapy in advanced melanoma
|
McDermott, David |
|
2014 |
40 |
9 |
p. 1056-1064 9 p. |
artikel |
3 |
Editorial Board
|
|
|
2014 |
40 |
9 |
p. IFC- 1 p. |
artikel |
4 |
Is the differentiation into molecular subtypes of breast cancer important for staging, local and systemic therapy, and follow up?
|
Sonnenblick, Amir |
|
2014 |
40 |
9 |
p. 1089-1095 7 p. |
artikel |
5 |
Prognostic relevance of receptor tyrosine kinase expression in breast cancer: A meta-analysis
|
Templeton, Arnoud J. |
|
2014 |
40 |
9 |
p. 1048-1055 8 p. |
artikel |
6 |
Progress in the knowledge and treatment of advanced pancreatic cancer: From benchside to bedside
|
Oettle, Helmut |
|
2014 |
40 |
9 |
p. 1039-1047 9 p. |
artikel |
7 |
Temporal changes in the efficacy of chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck: A systematic review and meta-analysis
|
Winquist, Eric |
|
2014 |
40 |
9 |
p. 1073-1079 7 p. |
artikel |
8 |
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma
|
Coiffier, Bertrand |
|
2014 |
40 |
9 |
p. 1080-1088 9 p. |
artikel |
9 |
Treatment-related dysgeusia in head and neck cancer patients
|
Irune, Ekpemi |
|
2014 |
40 |
9 |
p. 1106-1117 12 p. |
artikel |
10 |
Understanding the mechanisms of action of antiangiogenic agents in metastatic colorectal cancer: A clinician’s perspective
|
Clarke, J.M. |
|
2014 |
40 |
9 |
p. 1065-1072 8 p. |
artikel |